$94.08
Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
Iradimed Insider Sold Shares Worth $285,000, According to a Recent SEC Filing
Assessing IRADIMED (IRMD) Valuation After Strong Multi Year Returns And A Premium P/E Multiple
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It
Overview
52-week range
$55
$108
74% of range
Avg surprise (last 2)
+1.1%
Avg reaction (last 1)
-2.2%
0% positive
Latest IV / EM
45%
EM ±10.3% · $95 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $0.45 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.43 | — | — | — | — | financials |
| Fri Aug 1, 2025 | Jun/2025 | $0.45 | $0.41 | +9.8% | — | — | earnings |
| Mon May 5, 2025 | Mar/2025 | $0.37 | $0.40 | -7.5% | — | -2.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.40 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.38 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.32 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.40 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.33 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Fri Aug 7, 2026 | Jun/2026 | OTHER | $0.42 | $0.45 | -6.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22M | — | $21M | $20M | $20M | — | $18M | $18M |
| Cost of revenue | $5M | — | $5M | $4M | $5M | — | $4M | $4M |
| Gross profit | $17M | — | $16M | $16M | $15M | — | $14M | $14M |
| Operating income | $7M | — | $7M | $7M | $5M | — | $6M | $6M |
| Net income | $6M | — | $6M | $6M | $5M | — | $5M | $5M |
| EPS (diluted) | $0.45 | — | $0.43 | $0.45 | $0.37 | — | $0.40 | $0.38 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $56M | $51M | $57M | $53M | $50M | $52M | $52M | $49M |
| Inventory | $12M | $12M | $12M | $11M | $11M | $10M | $11M | $12M |
| Total current assets | $86M | $81M | $85M | $77M | $75M | $75M | $74M | $74M |
| Total assets | $114M | $109M | $115M | $106M | $102M | $98M | $94M | $90M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $16M | $14M | $16M | $12M | $12M | $12M | $11M | $10M |
| Total equity | $99M | $95M | $98M | $94M | $90M | $87M | $83M | $80M |